Should you have any questions or requests do not hesitate to contact us: http://biotalentumconsulting.eu/contact/
Please find here the summary of the relevant calls: /uploaded_files/files/calls%20with%20autumn%20deadlines_2016_PM_BIOTEC_NMBP_BIOT%283%29.pdf
This position will be the part of the project task characterization of pharmacokinetics and toxicology of the developed new nanoparticles. To fulfill this task, transcriptomic studies will be performed in in vivo mice models together with extensive bioinformatic analysis. Transcriptomic studies will be fulfilled by next generation sequencing (NGS) expression profiling. Great emphasis will be laid on the bioinformatic evaluation of results.
More information: http://nabbaproject.eu/job_vacancy
Please find here the first newsletter of our SCICHALLENGE project:
We are very glad to announce that BIOT has their 5th successful H2020 proposal!! smile hangulatjel
Project in3: An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment
Our role: ESR host on hiPSC reporter cell, trainings and secondments
FET Open continues to foster early-stage research for radically new technological possibilities. It supports promising novel ideas from all technological areas without prescribing any theme. Funding is available for Research and Innovation Actions as well as for Coordination and Support Actions. Two topics are currently open.
The EU SME eHealth Competition, supported by the European Commission, recognizes the best eHealth SMEs of Europe. This year's Competition Final will take place as a satellite event of the eHealth Week conference in Amsterdam. SMEs that match the criteria can apply until 29 February 2016.
Open Innovation 2.0 Conference 2016
During the Open Innovation 2.0 event several topics will discussed, like European Innovation Living labs; Innovation Ecosystems; OI2 funding opportunities under Horizon 2020; Online Engagement Platforms (Big Data, Cloud, IoT, participatory design); etc. The conference will be preceded by a Camp for Societal Innovation which will bring together people with different backgrounds to address the challenges brought by cities, regions, industry, universities and NGOs.
H2020 Open Innovation Related Calls
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020). It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
Which emerging fields of technological research should the EU be investing in? What novel areas of science, mathematics and technology would benefit from deeper exploration? Share your views by April 30th and help us identify where to focus our future work in Horizon 2020 – the EU's research and innovation framework programme.
The following topics are under consideration for inclusion in Calls for proposals to be launched in 2016: http://www.imi.europa.eu/content/future-topics
Looking for funding for your research and innovation project in eHealth and/or Active and Healthy Ageing?
Watch this video about the Horizon 2020 call for proposals: Societal Challenge 1 "Health, demographic change and wellbeing": https://youtu.be/vD4ijb0oAHA
SciChallenge addresses the increasing demand for professionals in the fields of natural sciences, technology, engineering and mathematics (STEM). The project therefore aims at making education and careers in the STEM-fields more attractive for young people. Using innovative digital techniques and social media, SciChallenge will launch a pan-European competition for getting young girls and boys between of 10 to 20 years excited about the STEM-topics.
More information: http://project.scichallenge.eu/
In February 2016, the European Commission will launch a public consultation to gather your ideas on what tomorrow's Future and Emerging Technologies (FET) programme should look like. Be ready to share your views and help identify the themes of tomorrow's FET programme (FET proactive and FET Flagships).
As far as we have already published, new H2020 calls for the next 2 years (2016-2017) are available.
In order to support our partners more efficiently in preparing for submissions Biotalentum Consulting has summarised the forthcoming ones in a table you can find here: /uploaded_files/files/new%20calls_2016%281%29.xlsx
Should you have any questions or requests do not hesitate to contact us: http://biotalentumconsulting.eu/contact/
According to a European Commission mapping report that shows the use of European Structural and Investment Funds (ESIF) between 2014 and 2020, the 28 EU Member States plan to spend EUR 3.8 billion on health infrastructure alone and a further EUR 954 million on the use of ICT in health.
Additionally, more than EUR 4 billion will be invested in access to healthcare (health care and social services combined) and Active and Healthy Ageing.
The mapping report also summarizes health investments from the Structural Funds in the 2007–2013 programming period.
More information in the report - 'Mapping of the use of European Structural and Investment Funds in health in the 2007-2013 and 2014-2020 programming periods'.
An Information Day is organised to present the first FET calls for proposals in 2016: FET Open topics for Research and Innovation Actions (RIA) and Coordination and Support Actions (CSA), and the FET Proactive topic "Emerging themes and communities".
On 10-11 December 2015, the Luxembourg EU Presidency will organise a conference on researchers' careers, focusing on the Marie Skłodowska-Curie Actions.
Our CEO, Prof. Andras Dinnyes will be among the presenters with this topic: "The SME challenge: How to harmonise MSCA training with product development objectives".
Biotalentum was a partner in the NAD project which resulted in the breakthrough described in the article:
An Integrated European ‘Flagship’ Program Driving Mechanism-based
Toxicity Testing and Risk Assessment for the 21st Century
In a large (30 Million €) H2020-supported collaborative project, academia joins forces with small and medium-sized enterprises (SMEs), large industry, contract research organisations (CROs) and regulatory bodies to achievea paradigm shift in toxicologytowards a more efficient and animal-free chemical safety assessment.
Gödöllő, 21 October 2015
An international consortium of 39 partner organisations will be funded by the European Commission to work on the integration of new concepts for regulatory chemical safety assessment. These new concepts involve cutting-edge human-relevant in vitro non-animal methods and in silico computational technologies to translate molecular mechanistic understanding of toxicity into safety testing strategies. The ultimate goal is to deliver reliable, animal-free hazard and risk assessment of chemicals.
Coordinated by Bob van de Water, Professor of Toxicology at Leiden University (The Netherlands), EU-ToxRisk intends to become the European flagship for animal-free chemical safety assessment. The project will integrate advancementsin cell biology, omics technologies, systems biology and computational modelling to define the complex chains of events that link chemical exposure to toxic outcome. The consortium will provide proof of concept for a new mechanism-based chemical safety testing strategy with a focus on repeated-dose systemic toxicity as well as developmental and reproductive toxicity. Importantly, novel mechanism-based test methods will be integrated in fit-for-purpose testing batteries that are in line with the regulatory framework and will meet industrial implementation. EU-ToxRisk will develop new quantitative risk assessment approaches based on understanding of so-called “Adverse Outcome Pathways” incorporating all mechanistic toxicity data available in the public domain. It will also achieve a rapid improvement of so-called “read across” approaches as the most important data-gap filling and hence animal-saving alternative method at present. Thus, the project strives towards faster safety evaluation of the many chemicals used by industry and society.
“BioTalentum Ltd as the only Hungarian partner, is proud, to be part of such a European flagship project and to provide our combined expertise in human pluripotent stem cells and molecular biology to generate novel fluorescent reporter cell lines to assess neurotoxicity in two and three dimensional neuronal networks” said Biotalentum General Director Prof Andras Dinnyes. “We have high expectations that this project will boost BioTalentum’s portfolio in neuronal assays for chemical and drug toxicity and further strengthen our ties with chemical, cosmetics and pharma industry profiting from the new platforms.”
The EU-ToxRisk project will kick-off in January 2016 and will run for six years.
For further information on EU-ToxRisk and the project partners see: www.eu-toxrisk.eu
For more information on the H2020 programme, visit:
Prof. Bob van de Water
Division of Toxicology
Leiden Academic Centre for Drug Research (LACDR)
Einsteinweg 55 / P.O. Box 9502 / 2300 RA LEIDEN / The Netherlands
Office: +31-71-5276223 / Secretariat: +31-71-5276270 / E-mail: email@example.com
Prof. Andras Dinnyes, General Director
BioTalentum Ltd, Aulich L u 26, Godollo, 2100, Hungary
Notes to editors
Full document available here: /uploaded_files/files/EU-ToxRisk_press%20release_en_long_BIOT%281%29.docx
The EU-funded BioHorizon project will host a Partnering Event in Brussels Sheraton Hotel on 26th November 2015 dedicated to ‘Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy’ (SC2) in Horizon 2020. Hosted in connection with the European Commission’s Open Info Day (25th November 2015), the objective of the brokerage event is to assist you in finding the right project partners for the upcoming Societal Challenge 2 calls for 2016. The new work programme addressing the challenge ‘Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy’ has just been launched and the first proposal submission deadlines will be at the beginning of 2016, making this the perfect opportunity for your institution to begin building a consortium.
Registration may close prior to the 8th November if the maximum number of participants is reached.
For more Information about the Info Week and to find out about and to register for other events, please visit the Commission's dedicated page here.
The European Commission will invest almost €16 billion in research and innovation in the next two years under Horizon 2020, the EU's research and innovation funding scheme, following a new work programme for 2016-17 adopted on 13 October.
The work programme is now available on the participant portal: http://ec.europa.eu/research/participants/portal/desktop/en/funding/reference_docs.html#h2020-work-programmes-2016-17
Biotalentum had a great success with their programme at the Researchers' Night at "Planetarium" (http://www.planetarium.hu/english) and had several enthusiastic visitors as well.
We had posters with cartoons about basics of epigenetics & DOHAD using animal model examples— environment impact including benefits of healthy foods & physical activity and another with animal cells - vegetal cells/difference. (Activity for children: drawing, highlighting the difference)
Visitors could do some pipetting water from culture dishes or test tubes and watch a movie of in vitro fertilisation and microscope slides. Finally there was a quiz with easy questions and answers.
Some pictures from the programme can be found here:
Nominations for the European Inventor Award 2016 are now open. The Award recognises outstanding inventors from around the world, from all technical fields and backgrounds. You don’t have to be an inventor yourself to put forward a nominee. People from industry, research institutes, IP associations and universities, as well as the general public, are all welcome to make a suggestion. So why not go ahead and nominate your favourite inventor? You can even nominate yourself if you want!
Deadline for submissions: 14 October 2015
More information: http://www.epo.org/learning-events/european-inventor/nominate.html
21 October 2015, Lissabon
During the ICT2015 conference, a set of expert speakers will address these issues from the academic, research, as well as public and private sector perspectives, looking at the current situation and how open access, open science and open research data can be converted into Innovation. We will consider how OpenAIRE has fostered this process, and how e-infrastructures can help fulfil its potential. And we'll consider the citizen's role and the potential benefits at individual as well as societal level, as well as the risks - and how they can be addressed.
The draft version of the FET Horizon 2020 work programme for 2016-2017 is being made public just before its adoption process to provide potential participants with its currently expected main lines. This document is not yet endorsed by the Commission and does not in any way prejudge the final decision of the Commission. Other draft H2020 work programmes are also available.
The adoption and the publication of the FET H2020 work programme by the Commission is expected by mid-October 2015. Only the adopted work programme will have legal value. You can check the draft version of FET H2020 work programme 2016-2017.
Draft work programmes related to other sections of H2020 are published here.
The ICT 2015 event in Lisbon (20-22 October) will comprise a number of parallel activities over the three days: the conference programme is complemented by thematic sessions about the work programmes 2016-2017, an exhibition area with more than 150 stands, and networking sessions.
Horizon 2020 Work programme 2016-2017 ‘Secure, Clean and Efficient Energy’: 6 November 2015, Charlemagne building, Brussels
The event targets potential applicants to the calls for project proposals under the Smart Cities & Communities topic of the Horizon 2020 Work programme 2016-2017 ‘Secure, Clean and Efficient Energy’.
Presentations will cover the Smart Cities & Communities part of the Work Programme for 2016-2017 and the application procedure, as well as detailed information on the calls. Participants will have numerous networking opportunities throughout the day.
Free and compulsory registration for the event will open soon.
The EU Prize for Women Innovators recognizes and celebrates women who have benefitted from EU funding related to Research and Innovation and who have combined their scientific excellence with an aptitude for business in setting up innovative enterprises and brought innovations to the market. After the successful forerunners in 2011 and 2014, the European Commission intends to award up to three Prizes for Women Innovators following a contest.
First prize: 100,000 EUR
Second prize: 50,000 EUR
Third prize: 30,000 EUR
Deadline to submit applications: 20 October 2015, at 17:00:00 (Brussels local time)
For further information on the prize contest, please visit www.ec.euroa.eu/women-innovators
Avoid this 9 pitfalls and increase you success chances in SME Instrument significatly
The NAD project (EU FP7 Large Scale Collaborative project) managed by BioTalentum Ltd. won the Second prize award in the section “Best Completed Project Contest” during the award ceremony that took place at Conference Dinner of Industrial Technologies 2014 Conference 2014 on April 10th, 2014.
The prize was been given to the project coordinator Prof. Massimo Masserini by Clara de la Torre, Director responsible for "Research and Innovation" in the European Commission.
We would like to inform you that the Horizon Prize for a Food Scanner has been officially launched.
The rules of the contest are now available online. You will be able to apply from 9 September until 9 March 2016.
The €1 million prize will be split into a maximum of three awards: € 800 000 will go to the winner and € 100 000 each to the first and second runner-ups.
Further information: https://ec.europa.eu/research/horizonprize/index.cfm?prize=food-scanner
The deadline for submissions is 14 October 2015.
More information is available here: http://www.epo.org/learning-events/european-inventor/nominate.html
The registrations for the Horizon Prizes for breaking the optical transmission barriers and collaborative spectrum sharing are now open. Innovators, SMEs and non-profit organisations can now formally register and submit their proposals.
AAL makes use of ICT in a person's daily living and working environment to enable them to stay active longer, remain socially connected and live independently into old age. Research efforts in AAL have increased rapidly to support independent living, as the social and economic impact of aging population has become a more concrete problem in our European society.
Horizon 2020 (2014-2020), the EU funding programme for research and innovation, puts emphasis on tackling societal challenges, including Societal Challenge 1 (SC1) related to Health Demographic Change and Wellbeing. Having at its core the principle of better health for all, SC1 focuses on personalised health and care. It has an overall budget of €7.4 billion for the programme duration. This Info Day will precede the adoption of the Work Programme 2016-2017 (SC1).
Up to the end of February 2015, after 14 months, Horizon 2020, the EU Framework Programme for Research and Innovation 2014-20, had received 45,000 applications. This represents a large surge in the number of applications.
The success rate for applications was 14% to 15% on average, while in Framework Programme 7 (2007-13), the predecessor of Horizon 2020, the success rate was between 19% and 22%.
More information: http://www.universityworldnews.com/article.php?story=20150617162927313
The first ten projects of the new Bio-Based Industries Joint Undertaking (BBI JU), a partnership between the EU and industry, will get underway with a total of €50 million from Horizon 2020, the EU's research funding programme, and a further €28 million from the industry. This is thanks to the signature of the grant agreements finalised today (15 June 2015).
The funded projects will cover research into specific bio-based materials with potential to replace fossil fuels and materials based on them. They also include an industrial-scale flagship project that will use oil crops such as cardoon, grown on arid and marginal lands, for the extraction of vegetable oils. These will then be converted into bio-products such as biolubricants, cosmetics, and bioplastics, and by- products from the process will be used to produce energy, animal feed and chemicals.
Registration for ICT 2015 has just opened. Register today and join the ICT enthusiasts from research and academia, politics, industry, start-ups, investors. Free registration gives you access to the ICT 2015 conference, networking, exhibition activities and much more!
Further information: https://ec.europa.eu/digital-agenda/en/news/registration-ict-2015-open
A prize of €1 million will be awarded to the person or team that develops a rapid test to tell whether a patient needs to be treated with antibiotics or not, the European Commission announced today. The aim is to stop overuse of antibiotics and halt the growing resistance of micro-organisms to them that causes every year 25 000 deaths and over €1.5 billion in healthcare expenses and productivity losses in Europe alone.
The Horizon Prize for better use of antibiotics is a challenge prize (also known as "inducement" prize) – it offers a cash reward to whoever can most effectively meet a defined challenge with a breakthrough solution. It leaves applicants total freedom to come up with the most promising and effective solution, be it from an established scientist in the field or from an innovative newcomer. The award criteria just require the test to be cheap, rapid, easy-to-use for healthcare providers and non- or minimally invasive for patients.
The rules of contest are now available online. Contestants will be able to submit their entries from 10 March 2015 until 17 August 2016.
IMI 2 – Call 3 is still open for submission of proposals – the deadline is 24 March 2015. Topics under the Call are:
- Remote assessment of disease and relapse (RADAR) - CNS
- Towards a quantitative biological approach for neuropsychiatry
- Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
- The consistency approach to quality control in vaccine manufacture
- Pertussis vaccination research
- Knowledge repository to enable patient focused medicine development
All Call documents, including a Q&A, can be found on the IMI 2 – Call 3 web page.
Information on the Calls can also be found in the webinar presentations
The European Commission launched the new, €200 million Fast Track to Innovation (FTI) pilot initiative to promote innovation by reducing the time it takes to bring innovative ideas to market. Over the next two years, the pilot initiative will be open to all types of participants, particularly from industry, while stimulating first-time applications from industry and SMEs to Horizon 2020, the EU's research and innovation funding programme.
Further details in the news alert: http://ec.europa.eu/research/index.cfm?pg=newsalert&year=2015&na=na-090115
17 December was the last cut-off date in 2014 for Horizon 2020’s SME Instrument (2,992 new proposals from 35 countries: 2,363 for phase 1 and 629 for phase 2) The topic generating the most proposals for both phases is still ICT / Open Disruptive Innovation.
The applicants will be informed of the results of the evaluation in February for phase 1 and April for phase 2.
Further details: https://ec.europa.eu/easme/en/news/horizon-2020-s-sme-instrument-2992-new-proposals-received-december-2014
Companies selected for funding under the SME Instrument of Horizon 2020, the EU Research and Innovation programme (as of 18/09/2014)
Deadline for applications for SME Instrument phase 2 (first cut-off date) was 9 October 2014. Executive Agency for SMEs received 580 proposals.
Eurostars-2 – About 800 SMEs participated in the second cut-off
24 September 2014 was the second cut-off date for Horizon 2020’s SME Instrument phase 1. EASME received 1,944 new proposals, which makes in total more than 4,600 when adding up the applications submitted in June.
The ranking by country remains the same as in June, with Italy in the lead in terms of number of applications (351), followed by Spain (283), United Kingdom (149), Germany (128), France (93) and Hungary (91).
The aim of the D-BOARD consortium is to bring together leading academic institutions and European SMEs to focus on the identification, validation and qualification of new combination biomarkers and the development of diagnostic tests capable of subclinical disease diagnosis for degenerative and inflammatory diseases of joints.
On 12 September 2014 the Federal Administration informed that Switzerland has now the status of an Associate Country (AC) under the first pillar. This partial association allows researchers in Switzerland to again participate as associated and equally entitled partners in all activities under the first pillar of Horizon 2020, comprising ERC grants, Marie Skłodowska-Curie Actions, Future and Emerging Technologies (FET) and research infrastructures, from September 15, 2014.
Researchers in Switzerland will also be able to participate as associated partners in the programme section on Spreading Excellence and Widening Participation. As associated partners, researchers in Switzerland will again receive direct funding from the EU.
For all other Horizon 2020 calls Switzerland remains a third country entity (Third Country (TC) Status).
The European Commission has published a list of the 155 small and medium-sized enterprises (SMEs) that will be first to benefit from its new €3 billion SME Instrument. 155 SMEs from 21 countries will each receive €50,000 to finance feasibility studies for their projects, and they can also benefit from up to three days of business coaching. After that, their projects may be considered for further financial support from the Commission worth up to €2.5 million.
Further information: http://europa.eu/rapid/press-release_IP-14-1015_en.htm
It is our great pleasure to announce, that the NABBA project has been accepted by the EU for funding.
The proposal submission was supported by BioTalentum Consulting. The Branch will provide soft-skill trainings for the recruited fellows.
Within the scope of this program, led by our partner Universita’ Degli Studi Di Milano-Bicocca and with the participation of 4 further academic, 2 industrial partners and 4 partner organisations, the “NABBA - Design and Development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases” project is aimed to provide cutting edge and high medical and societal impact sciencefor the multidisciplinary and intersectoral training of 12 ESRs.
For further information about the call and the statistics please see the EU announcements: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-msca-itn-2014.html
The synchronisation of national funding for the first cut-off of the transnational programme Eurostars-2 has recently been concluded. Of the 299 applications for funding submitted, 82 were positively evaluated and the best 70 were selected to be part of the programme, representing an overall success rate of 23%.
SMEs are the main beneficiaries; out of 928 organisations, 659 were SMEs, representing 70% of the participants and 78% of the total project costs.
Some statistics about the results: http://eureka.cmail2.com/t/ViewEmail/t/05710D411695DE62/2B239497581A14692540EF23F30FEDED
As the SME Instrument is a brand new funding opportunity, we did not know what to expect from the first round of applications. As we said on many occasions, the Instrument is very selective and only the best of the best can succeed. We received some excellent proposals – 155 champions of innovation will soon get €50,000 to finance a feasibility study. But many proposals that were not good enough to compete in the innovation champions’ league.
Here are 6 lessons we learnt from this very first evaluation exercise that we think can be useful for the future applicants.
Most of the non-selected proposals were:
- Too much focused on the project and not enough on the business opportunity;
- Not convincing when describing the company (you have to explain why your company will succeed and not your competitor);
- Not providing enough information on competing solutions;
- Having a too low level of innovation, planning to develop a product that already exists on the market;
- Proposing just an idea without any concept for its commercialisation;
- Just trying their luck (the SME Instrument is not a lottery!).
The evaluation of proposals submitted before the first cut-off date for Phase 1 (18 June) is over. 155 projects from 21 countries have been pre-selected for funding. Out of the 2 666 proposals submitted, 2602 were eligible and 317 got a score above the threshold. 49% of these are pre-selected for funding.
The new Eurostars-2 call is now open for applications. The cut-off deadline of the Eurostars-2 Programme’s second call will be September 11, 2014 at 20:00 CET.
More information: https://www.eurostars-eureka.eu/
Five Western Balkan countries (Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro and Serbia), and the Republic of Moldova today secured full access to the European Union's new seven year research and innovation programme, Horizon 2020.
The Federal Council approved interim measures in response to the unresolved situation regarding Switzerland’s association to Horizon 2020, the EU Framework Programme for Research and Innovation.
The European Commission has received a deluge of 16,000 applications in the first round of calls for Horizon 2020, its €80 billion research and innovation programme. The Commission’s first set of calls totaled €15 billion, and it received nine times that worth in applications, that’s almost double the oversubscription rate in the first round of the previous research programme, the Seventh Framework Programme (FP7). Given the strong surge in bids, the first-round success rate for Horizon 2020 applications will drop to 11 per cent, half the figure in FP7.
Nearly half of all applicants were from industry compared with 29 per cent in FP7. Of all industry applicants in the first H2020 calls, half were SMEs. Among the calls, launched in mid-December, the most heavily-subscribed areas were those relating to health topics but also food, ICT and cyber-security.
BioFIT aims at stimulating and facilitating technology transfer and collaborative projects between academic institutions, pharma/biotech industry, together with other practitioners in the Life Sciences field.
BioFIT is an ideally configured event featuring: • Partnering with qualified and pre-screened one-to-one meetings • Conferences to explore hands-on approaches to tech transfer and Open Innovation • Presenting technologies, licensing opportunities.
Further information: http://www.biofit-event.com/
Marie (Skłodowska-)Curie fellows enjoy greater success in obtaining grants from the European Research Council (ERC) than their peers, according to a report.
The study from the European Commission finds that researchers who have held a Marie (Skłodowska-) Curie fellowship, which funds a period of exchange to a foreign institution, are more likely to be awarded an ERC grant for research excellence. This also extends to other internationally-recognized awards, with female Marie Curie researchers having a 13 per cent greater probability of obtaining high-profile awards later in their career than non-Marie Curie fellows, reports the study.
Other benefits of the programme include publication success, with Marie Curie fellows recording more articles in higher-profile journals and better citation records, finds the report, available on the website of the Directorate General for Research and Innovation.
BIO-Europe® is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. In addition to productive partnering, BIO-Europe offers high level workshops, panels, company presentations, and a lively exhibition.
Further information: http://www.ebdgroup.com/bioeurope/index.php
IMI will hold three webinars on topics of its 1st Call for proposals under IMI 2, as well as its new rules and procedures and intellectual property rights (IPR) in July 2014. The webinars will represent an excellent opportunity to learn more about the topics, interact directly with the topic coordinators, and get in touch with potential project partners. Start date of the webinar: 11/07/2014, end date: 15/07/2014.
Information will be also available on Open Info Day on its IMI 2-Call 1 in Brussels, on Tuesday 30 September 2014. The day will include an overview of IMI 2’s funding and intellectual property (IP) rules, tips on applying for funding under IMI 2, and workshops and presentations of the IMI 2-Call 1 Call topics by the project coordinator.
Returning for its seventh year as the industry pioneering and leading event, the 7th annual Advances in Cell Based Assays Conference /11th-12th November, 2014, London/ will explore latest trends and topics impacting cell based assays, discussed in an open and dynamic environment. The event will discuss key topics such as, phenotypic screening using cell based assays, application of 3D cultures, stem cells, label free technology as a way to innovate medicine plus much more
Further iformation: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/cell-based-assays
The Participant Portal, the central web platform for EU research and innovation funding, is improving its user-friendliness and functions for H2020. You can learn more at the webinar on 24 June.
On 8th June 2014 Israel's association to Horizon 2020, the new EU research and innovation programme was signed. Horizon 2020 offers a huge opportunity to enhance the traditionally active cooperation between Israeli and EU researchers and innovators. Under the terms of the agreement, Israel will have the same access to the programme as EU Member States and other Associated Countries. In return, it will contribute to the Horizon 2020 budget
More information: http://europa.eu/rapid/press-release_IP-14-633_en.htm
Turkey will get full access to the European Union's new seven year research and innovation programme, Horizon 2020, under an agreement signed today in Istanbul. Turkey has been associated to EU research framework programmes since 2003. Under the last programme (2007-13) over 1,000 participations from Turkish public and private institutions in some 950 projects received almost €200 million in EU funding.
In parallel to the agreement reached with Turkey, the EU is in the process of concluding association agreements with enlargement countries from the Western Balkans and other neighbouring countries. The EEA/EFTA states of Norway and Iceland joined Horizon 2020 at the beginning of May.
Further information: http://europa.eu/rapid/press-release_IP-14-631_en.htm
The event will start of with an information day and consortium building event addressing the FET Open and FET High Performance Computing calls for proposals. This discussion is an opportunity to share experiences and think about the participation in FET (Future Emerging Technologies) projects by researchers from all over Europe, enabling talent from new Member States to reach their full potential. Whether leading the next new project or setting up a collaboration with researchers on other countries – this is an opportunity to see how the most creative minds can be reached by FET.
More information: http://www.fet2020.eu/
The Innovative Medicines Initiative (IMI) is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients. The goal of the IMI 2 is to develop next generation vaccines, medicines and treatments, such as new antibiotics. IMI 2 will start in 2014 and will run for 10 years. IMI 2 aims to deliver: a 30% better success rate in clinical trials of priority medicines identified by the WHO; clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases in just five years; new and approved diagnostic markers for four of these diseases and at least two new medicines which could either be new antibiotics or new therapies for Alzheimer’s disease.
The following topics are under consideration for inclusion in the Calls for proposals that will be launched in 2014 under IMI 2 (Call1):
- Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)
- Discovery and validation of novel endpoints in retinal diseases
Future topics - IMI 2 2014:
- RADAR: Remote assessment of disease and relapse
Further information: http://www.imi.europa.eu/content/future-topics
The 2nd Scientix Conference will take place 24 – 26 October 2014 in Brussels, Belgium. With the expected participation of around 550 teachers, policymakers, researchers and project managers, it will be one of the major networking events in STEM education in Europe.
The participation will be free of charge. Moreover, accommodation (Friday 24 and Saturday 25) will be covered for all 550 participants, as well as all meals from Friday night to Sunday lunch.
More information: http://www.scientix.eu/web/guest/conference
Climate-KIC creates opportunities for innovators to address climate change and shape the world’s next economy. CleanLaunchpad is Europe’s largest cleantech business idea competition. The mission is to unlock Europe’s cleantech potential. Start-ups that address climate change and shape the world’s next economy will be supported. In three stages the CleanLaunchpad competition leads-up to the EU finals in October in Valencia, Spain. The winner of the EU final receives € 10,000, the runner up gets € 5,000 and the idea that comes in third place wins € 2,500. And the real prize is that these three winners also get accepted into the Climate-KIC Accelerator, the world’s first real-life business school for promising cleantech entrepreneurs.
Further information: http://cleanlaunchpad.eu/
Considering the complex challenges raised by bringing biorefineries into the industrial arena, the European Biorefining Training School, founded in 2011, aims to offer an introduction to the key subjects and provide insight into many of the diverse issues that surround the bioeconomy transition. The training school will take place in Budapest, on July 7-10 and is a concept developed and trademarked by three world-class research institutes: National University of Athens of Greece, Wageningen University of the Netherlands and INRA of France and has secured Novozymes as main sponsor for its third edition. The school offers a chance for PhD students, decision makers and professionals on the emerging field of bioeconomy to learn about the latest knowledge and developments by internationally renowned researchers. It is also an excellent opportunity to visit three Hungarian biorefining factories, to learn about currently available methods and good practices in the region.
Further information: http://klimainnovacio.hu/en/biorefineryschool
CAPS2014 is a two-day international event, organized under the aegis of the European Commission. On July 1, the CAPS2014 OFF part of the event, held at The Egg, will offer a dynamic schedule of talks, unconferences, workshops, hands-on sessions and networking moments. On July 2, the CAPS2014 Conference part, held at the European Commission, will provide participants with an overview of current projects and initiatives, and with detailed information of the upcoming CAPS Call under Horizon 2020.
Further information: http://caps-conference.eu/
The Deloitte Technology Fast 50 Program award honors the fastest growing Central European technology companies, based on the percentage of revenue growth over five-year period. This competition is a Deloitte initiative on a regional and global level that aims to draw attention to fast-growing companies and to highlight companies who are just establishing themselves on the market.
More information: http://www.deloitte.com/view/en_HU/hu/industries/tmt/fast50/index.htm
The aim of founding the CSR Hungary Award has been to replace high-profile quantitative indicators with qualitative ones, i.e. cr should be based on real value instead of media presence, “obligatory” reports and marketing stunts. The award provides large-scale publicity for outstanding individual or corporate CSR performance, increasing the reputation (and in this way goodwill) of companies in Hungary and abroad.
Further information: http://www.csrhungarydij.eu/palyazzon/
Iceland and Norway on Friday became the first non-EU countries to associate to Horizon 2020, the seven-year EU research and innovation programme launched in January. The decision, taken at a meeting of the European Economic Area (EEA) Joint Committee, takes effect from the beginning of Horizon 2020 allowing these two countries' researchers and companies to participate on the same basis as their counterparts in the EU. In return, the two countries will contribute financially to Horizon 2020, the biggest ever EU research and innovation programme with a budget of nearly €80 billion.
More information: http://europa.eu/rapid/press-release_IP-14-566_en.htm
On 6 May 2014, the ECOFIN Council adopted the innovation investment package of public and private partnerships that will allow large-scale innovation projects to be carried out under Horizon 2020. This innovation package will contribute to implementing the Innovation Union strategy and has a budget of up to € 22 billion. This investment will contribute to the Joint Technology Initiatives (JTIs) in the fields of bio-based industries (BBI), aeronautics (Clean Sky 2), electronics (ECSEL), fuel cells and hydrogen (FCH 2) and innovative medicines (IMI 2), as well as to the public-public partnerships as set up in Article 185 of the EU Treaty.
For further information: http://era.gv.at/directory/142
The submission service of the Marie Skłodowska-Curie Individual Fellowships (IF-EF) has been opened.
The submission session is now available for: MSCA-IF-2014-EF(MSCA-IF-EF-ST) and MSCA-IF-2014-EF(MSCA-IF-EF-CAR) on the following page:
Objective of the consultation: Informing the review of the Europe 2020 strategy and seeking your views on its further development.
Policy Fields: Economic and financial affairs; competitiveness; industry; single market; employment; research, development and innovation; the digital economy; climate, energy and resource efficiency; education and training; poverty and social exclusion.
Period: The consultation will be open from 5 May 2014 to 31 October 2014.
More information: http://ec.europa.eu/europe2020/public-consultation/index_en.htm
István Harsányi Prize is given to reward the authors of high level diploma projects, PhD dissertations, or projects of students science research associations in the field of management, for c. 10 university students, annually.
More information: http://www.innovacio.hu/en_3e.htm
First Horizon 2020 calls launched!
A competitive call for proposals offering the EU-funded Marie Skłodowska-Curie Individual Fellowships(IF) for a total of €240.50 million opens today. The fellowships will support individual researchers at postdoctoral level and beyond working on their personal research projects in a host institution.
Read the news: http://ec.europa.eu/rea/about_us/news/2014_03_12_news_en.htm
Intel Business Challenge Europe 2014 is a competition for innovative products, smart technologies and interactive web & mobile applications in the areas of: Healthcare & Medical devices, Energy and Cleantech, People & Society, ICT, Biotechnology, Nanotechnology.
It is an excellent opportunity for teams to learn about how to develop and idea and turn it into a company as well as a chance to promote their project to a valuable network of entrepreneurs, academics, and investors.
More information: http://www.intelchallenge.eu
Dr. Andras Dinnyes presented the Marie Sklodowska-Curie Actions - H2020 (EU) on the workshop "Advancing Your Research Cereer in Europe - Funding and Fellowship Opportunities for Southeast Asian Researchers" on 22nd January in Bangkok, Thailand and 24th January 2014. at One-North, Singapore.
Our first newsletter avaliable HERE
The European Parliament has today given its consent to the EU budget 2014-2020. The budget as agreed includes nearly €80 billion for Horizon 2020, the EU's next research and innovation programme. This is a real increase of nearly 30% over the current framework programme, FP7.
Full press release HERE
The first Hungarian IP legal clinic started to work in cooperation of Hungarian Association for Innovation and Eötvös Lorand University. The startups get free support in literary property (eg. softwer), trademark property and the field of commercial name (also domain name).
Furter information: http:// http://www.innovacio.hu/misz_index_jogi_klinika.html
Erasmus+ is the new EU programme for Education, Training, Youth and Sport for 2014-2020, starting in January 2014. Erasmus+ aims at boosting skills and employability, and modernising Education, Training and Youth work. Erasmus+ will provide opportunities for over 4 million Europeans to study, train, gain work experience and volunteer abroad. In addition to providing grants for individuals, Erasmus+ will support transnational partnerships among Education, Training and Youth institutions and organisations to foster cooperation and bridge the worlds of Education and work in order to tackle the skills gaps we are facing in Europe.
Further information: http://ec.europa.eu/programmes/erasmus-plus/index_en.htm
After hard-fought negotiations with governments, Parliament is set to give its consent to the EU’s €908 billion long-term budget for 2014-2020, the so-called Multi-Annual Financial Framework (MFF). (Tuesday) It can then vote on the various EU investment programmes e.g. for agriculture, regional development, research, the environment, culture, education, social cohesion and more. Many of the programmes have been significantly altered by Parliament in its negotiations with the Council.